<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Afr Health Sci</journal-id><journal-id journal-id-type="iso-abbrev">Afr Health Sci</journal-id><journal-title-group><journal-title>African Health Sciences</journal-title></journal-title-group><issn pub-type="ppub">1680-6905</issn><issn pub-type="epub">1729-0503</issn><publisher><publisher-name>Makerere Medical School</publisher-name><publisher-loc>Kampala, Uganda</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5656201</article-id><article-id pub-id-type="publisher-id">jAFHS.v17.i3.pg762</article-id><article-id pub-id-type="doi">10.4314/ahs.v17i3.19</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Hepatitis B virus DNA polymerase gene polymorphism based prediction of genotypes in chronic HBV patients from Western India </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chavan</surname><given-names>Yashwant G</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Pawar</surname><given-names>Sharad R</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wani</surname><given-names>Minal</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Raut</surname><given-names>Amol D</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Misra</surname><given-names>Rabindra N</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref></contrib></contrib-group><aff id="A1"><label>1</label> Dr. D Y Patil Biotechnology and Bioinformatics Institute, Tathwade, Pune 411033. Dr. D Y Patil Vidyapeeth, Sant Tukaram Nagar, Pimpri, Pune 411018. Maharashtra, India</aff><aff id="A2"><label>2</label> Medical Genetics, geneOmbio Technologies Private Limited, Baner, Pune 411045. Maharashtra, India</aff><aff id="A3"><label>3</label> Department of Microbiology, Dr. D Y Patil Medical College, Dr. D Y Patil Vidyapeeth, Sant Tukaram Nagar, Pimpri, Pune 411018. Maharashtra, India</aff><author-notes><corresp>Corresponding author: Yashwant G Chavan Dr. D Y Patil Biotechnology and Bioinformatics Institute, Tathwade, Pune 411033. Dr. DY Patil Vidyapeeth, Sant Tukaram Nagar, Pimpri, Pune 411018. Maharashtra, India. Phone +91-9881927528 <email>visualyash10@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2017</year></pub-date><volume>17</volume><issue>3</issue><fpage>762</fpage><lpage>772</lpage><permissions><copyright-statement>Copyright © Makerere Medical School, Uganda 2017</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>@ 2017 Chavan et al; licensee African Health Sciences. This is an Open Access article distributed under the terms of the Creative commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0">https://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract abstract-type="executive-summary"><sec><title><text><SENT sid="1" pm="."><plain>Background </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="2" pm="."><plain>Hepatitis B Virus (HBV) infection is one of the major causes of liver cirrhosis, hepatocellular carcinoma and deaths due to the acute or chronic consequences worldwide. </plain></SENT>
<SENT sid="3" pm="."><plain>HBV is distributed into various genotypes based on nucleic acid sequence variation. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="4" pm="."><plain>Objectives </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="5" pm="."><plain>To develop a method of HBV genotyping and drug resistance interpretation using partial sequencing of polymerase gene. </plain></SENT>
</text></SecTag></p></sec><sec sec-type="methods"><title><text><SENT sid="6" pm="."><plain>Methods </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="7" pm="."><plain>This study was performed on 98 HBV infected patients' serum samples from Western India. </plain></SENT>
<SENT sid="8" pm="."><plain>A nested PCR protocol was designed for amplification of pol gene from HBV genome and Sanger's sequencing of the gene fragment. </plain></SENT>
<SENT sid="9" pm="."><plain>Sequences were aligned with HBV reference sequences for phylogenetic analysis and for characterization of genetic diversity. </plain></SENT>
<SENT sid="10" pm="."><plain>Drug resistance mutations were screened using HBVSeq program from Stanford University. </plain></SENT>
</text></SecTag></p></sec><sec sec-type="results"><title><text><SENT sid="11" pm="."><plain>Results </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="12" pm="."><plain>Distribution of HBV genotypes showed predominance of genotype D, circulating in 76 (77.55%) patients (p &lt; 0.05). </plain></SENT>
<SENT sid="13" pm="."><plain>Genotypes A and C were less prevalent and were identified in 4 (4.08%) and 18 (18.37%) patients, respectively. </plain></SENT>
<SENT sid="14" pm="."><plain>Anti-retroviral drug resistance mutations were not detected in any patient. </plain></SENT>
</text></SecTag></p></sec><sec sec-type="conclusions"><title><text><SENT sid="15" pm="."><plain>Conclusion </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="16" pm="."><plain>A method for determination of HBV genotypes using pol gene sequencing which simultaneously detects major drug resistance mutations has been established. </plain></SENT>
<SENT sid="17" pm="."><plain>HBV genetic diversity may play an important role in treatment decision. </plain></SENT>
</text></SecTag></p></sec></abstract><SecTag type="KEYWORD"><kwd-group><kwd>Hepatitis B virus</kwd><kwd>nested PCR</kwd><kwd>genotype</kwd><kwd>sub-genotypes</kwd><kwd>YMDD mutations</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec sec-type="intro"><title><text><SENT sid="18" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="19" pm="."><plain>HBV infection is a major health care problem with up to 400 million affected persons worldwide and accounts for one million deaths worldwide from cirrhosis, liver failure and hepatocellular carcinoma.1 HBV has been broadly classified into eight genotypes, designated as A–H.2 This classification is based on inter-genotypic divergence of at least 8% in the complete nucleotide sequence or more than 4% in the S gene.3 Evidence from various research studies has suggested that HBV genotypes may play some role in causing different disease profiles in chronic hepatitis B (CHB).4 Among Asians, who constitute greater than 75% of the worldwide population of individuals with CHB, genotypes B and C are the two most common HBV genotypes in Asia and Oceania.5 Genotype D is most widely distributed and found in Africa, Europe, Mediterranean countries, India, Indonesia and Nigeria.6 </plain></SENT>
</text></p><p><text><SENT sid="20" pm="."><plain>Correlation of genotypes with severity of infection has also been established. </plain></SENT>
<SENT sid="21" pm="."><plain>Researchers have found the association of genotype C with more severe liver disease as compared to genotype B and higher incidence of HCC in genotype D infected patients.7 In Europe, most patients with genotype D are reported to have acute hepatitis B, while most patients with genotype A have chronic hepatitis B.8 Association study in patients on Lamivudine therapy showed that patients with genotype D achieved higher SVR (Sustained viral response) than with genotype A; hence response to therapy is also found to be ruled by genotypes.9 Due to these important findings, HBV genotyping has gained immense importance in guiding treatment decisions, improving vaccination, and controlling liver diseases. </plain></SENT>
<SENT sid="22" pm="."><plain>Various methods of genotyping are available of which sequencing of S gene was mostly performed in the previous studies. </plain></SENT>
<SENT sid="23" pm="."><plain>Ying et al., performed semi-nested PCR amplification (using three primers) of pol gene and its sequencing for HBV genotyping in Chinese patients.10 In this study, we used nested PCR that uses four primers that results in increased specificity. </plain></SENT>
<SENT sid="24" pm="."><plain>As this assay is performed on low viral load samples, it also underlines higher sensitivity of nested PCR approach. </plain></SENT>
<SENT sid="25" pm="."><plain>Advances in molecular biology techniques have led to implementation of real time PCR for detection of HBV genotypes using melting curve analysis.11 This study comprises HBV polymerase gene sequencing covering YMDD region which also includes the overlapping S gene region, it was found that the sequence can be used to identify the genotype of the virus. </plain></SENT>
<SENT sid="26" pm="."><plain>This genotyping method makes use of Sanger's DNA sequencing technology to sequence HBV DNA polymerase region using different set of primers to amplify the HBV DNA polymerase and overlapping S gene region. </plain></SENT>
<SENT sid="27" pm="."><plain>Along with genotyping of Hepatitis B virus, this method also helps in determination of drug resistance mutation in YMDD hot-spot region of DNA polymerase gene. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials|methods"><title><text><SENT sid="28" pm="."><plain>Materials and methods </plain></SENT>
</text></title><sec><title><text><SENT sid="29" pm="."><plain>Study participants </plain></SENT>
</text></title><p><text><SENT sid="30" pm="."><plain>Four hundred and twenty seven chronic HBV infected patient serum samples were received at Molecular Diagnostic Lab of geneOmbio Technologies Private Limited (Pune, India) during March 2012 to May 2014 from associated hospital laboratories located in Western Indian states of Maharashtra, Goa and Gujrat. </plain></SENT>
<SENT sid="31" pm="."><plain>This was a retrospective cross-sectional study and all procedures conformed to the ethical guidelines of the 1975 Helsinki Declaration. </plain></SENT>
<SENT sid="32" pm="."><plain>No personal identification information or other personal identifiers such as address or hospital identification number were recorded to ensure patient confidentiality. </plain></SENT>
<SENT sid="33" pm="."><plain>This study was approved ethically by the Institutional Review Board (IRB) of geneOmbio Technologies (Approval No. IRB/2012/G-011) and Institutional Biosafety Committee (IBSC) at Dr. D. Y. </plain></SENT>
<SENT sid="35" pm="."><plain>Patil Vidyapeeth, Pune. </plain></SENT>
<SENT sid="36" pm="."><plain>The serum samples were collected and stored at −40°C until use. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="37" pm="."><plain>Inclusion criteria </plain></SENT>
</text></title><p><text><SENT sid="38" pm="."><plain>Patients with HBeAg and HBsAg positive sera confirmed by HbeAg/HbsAg Rapid Test Kit (Medical Biological Services, Italy) and having viral load in the range of 7-110000000 HBV DNA IU/mL were included. </plain></SENT>
<SENT sid="39" pm="."><plain>HBV viral load was determined using Roche COBAS TaqMan 48 Kit on COBAS TaqMan 48 Analyzer (Roche Molecular Systems, USA). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="40" pm="."><plain>Exclusion criteria </plain></SENT>
</text></title><p><text><SENT sid="41" pm="."><plain>Patients positive for Hepatitis C virus (HCV) and Human Immunodeficiency virus (HIV) anti-body test were excluded from the study. </plain></SENT>
<SENT sid="42" pm="."><plain>Screening for HCV and HIV-1 was done using commercially available HCV TRI DOT and HIV TRI DOT kit (J. </plain></SENT>
<SENT sid="43" pm="."><plain>MITRA &amp;Co. </plain></SENT>
<SENT sid="44" pm="."><plain>Ltd., New Delhi, India). </plain></SENT>
<SENT sid="45" pm="."><plain>Patients having viral load undetectable or less than 7 HBV DNA IU/mL were also excluded from the study. </plain></SENT>
<SENT sid="46" pm="."><plain>Of the 427 samples, 140 patients were both HBeAg and HBsAg positive. </plain></SENT>
<SENT sid="47" pm="."><plain>Thirty eight of these 140 patients had HBV viral load undetectable or less than 7 HBV DNA IU/mL, therefore were excluded from the study. </plain></SENT>
<SENT sid="48" pm="."><plain>Four samples were excluded due to co-infection with either HCV or HIV. </plain></SENT>
</text></p><p><text><SENT sid="49" pm="."><plain>Hence this retrospective cross-sectional study examined only a total of 98 (70 males, 28 females, mean age 43.8 + 11.6 years) patients. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="50" pm="."><plain>Primer design </plain></SENT>
</text></title><p><text><SENT sid="51" pm="."><plain>Twenty three full-length HBV sequences representing all of the available HBV genotypes were downloaded from GenBank nucleotide sequence database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</ext-link>). </plain></SENT>
<SENT sid="52" pm="."><plain>These sequences were selected from list provided by NCBI Genotyping tool (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/genotyping">http://www.ncbi.nlm.nih.gov/projects/genotyping</ext-link>) as reference set of sequences for HBV genotyping. </plain></SENT>
<SENT sid="53" pm="."><plain>Using ClustalW multiple sequence alignment tool the reference sequences were aligned to find the conserved domains.12 First round PCR primers YMDDF1 (5′- CAAGGTATGTTGCCCGTTTG-3′) and YMDDR1 (5′-CCCAACTCCTCCCAGTCCTTAA-3′) were selected from previously published data.13,14 With the help of Primer 3- Online Primer designing tool (<ext-link ext-link-type="uri" xlink:href="http://primer3.ut.ee">http://primer3.ut.ee</ext-link>), we designed a nested PCR primer pair YMDDF2 (5′ -CTGTATTCCCATCCCATCATC-3′) and YMDDR2 (5′-GACCCACAATTCGTTGACATAC-3′). </plain></SENT>
<SENT sid="54" pm="."><plain>The primers were synthesized at Eurofins Genomics Pvt. </plain></SENT>
<SENT sid="55" pm="."><plain>Ltd. </plain></SENT>
<SENT sid="56" pm="."><plain>(Bangalore, India). </plain></SENT>
<SENT sid="57" pm="."><plain>The amplified fragment of the polymerase gene overlaps slightly with the S gene. </plain></SENT>
<SENT sid="58" pm="."><plain>First round PCR primers were expected to generate 1290 bp amplicons whereas the nested PCR primers were expected to generate 409 bp amplicons. </plain></SENT>
<SENT sid="59" pm="."><plain>Implementation of nested PCR protocol enhances the sensitivity of the assay as it can amplify samples having very low HBV DNA viral load. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="60" pm="."><plain>DNA isolation, PCR and sequencing of HBV polymerase gene </plain></SENT>
</text></title><p><text><SENT sid="61" pm="."><plain>DNA isolation from serum samples was performed using High Pure Viral Nucleic Acid Kit (Roche Molecular Systems, USA) according to the manufacturer's instructions. </plain></SENT>
<SENT sid="62" pm="."><plain>PCR amplification was performed using Platinum Taq DNA Polymerase (Invitrogen Corporation, USA). </plain></SENT>
</text></p><p><text><SENT sid="63" pm="."><plain>The fragment of the polymerase gene was amplified by nested PCR with two rounds of amplification. </plain></SENT>
<SENT sid="64" pm="."><plain>Five mi croliter of DNA isolated from each patient was added to a 20 µL PCR mixture. </plain></SENT>
<SENT sid="65" pm="."><plain>The PCR mix contained 2.5 µl of 10x PCR buffer (100 mM Tris- pH 9.0, 500 mM KCl, 15mM MgCl2 and 0.1% Gelatin), 200 µM dNTPs, 1 unit of Platinum Taq DNA polymerase, 20 pM each of YMDDF1 and YMDDR1 primers for first round PCR and sterile nuclease free water to make a final volume of 25 µl. </plain></SENT>
<SENT sid="66" pm="."><plain>The first round of amplification was performed with an initial 5 min denaturing step at 95°C, followed by 30 cycles of denaturing for 45 s at 94°C, annealing for 30 s at 60°C, and elongation for 1 min at 72°C, with a final extension period of 10 min at 72°C. </plain></SENT>
<SENT sid="67" pm="."><plain>The second round of amplification was performed using 20 pM each of YMDDF2 and YMDDR2 primers, with an initial 5 min denaturing step at 94°C, followed by 30 cycles of denaturing for 45 s at 94°C, annealing for 30 s at 55°C, and elongation for 30 s at 72°C, with a final extension period of 10 min at 72°C. </plain></SENT>
<SENT sid="68" pm="."><plain>The reaction products of the nested PCR were visualized on a 2% (w/v) agarose gel stained with ethidium bromide. </plain></SENT>
<SENT sid="69" pm="."><plain>Purification of nested PCR products was performed using Purelink PCR product purification kit (Life technologies, USA). </plain></SENT>
<SENT sid="70" pm="."><plain>Automated DNA sequencing was performed using BigDye Terminator v3.1 Cycle sequencing kit on 3130 Genetic Analyzer (Applied Biosystems, USA). </plain></SENT>
<SENT sid="71" pm="."><plain>Nucleotide sequences were submitted to NCBI nucleotide sequence database GenBank. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="72" pm="."><plain>Determination of HBV Genotypes and phylogenetic analysis </plain></SENT>
</text></title><p><text><SENT sid="73" pm="."><plain>NCBI HBV genotyping tool (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/genotyping">http://www.ncbi.nlm.nih.gov/projects/genotyping</ext-link>) was used for determination of genotype for each HBV sequence. </plain></SENT>
<SENT sid="74" pm="."><plain>Nucleotide sequences of 336 bases generated after sequence quality trimming using Chromas Pro 1.34 (Technelysium Pty. </plain></SENT>
<SENT sid="75" pm="."><plain>Ltd., Queensland, Australia) were used for homology and phylogenetic analysis. </plain></SENT>
<SENT sid="76" pm="."><plain>Sequences were aligned by using the ClustalW program. </plain></SENT>
<SENT sid="77" pm="."><plain>Two representative reference sequences from each genotype were used for construction of phylogenetic tree (A: AF418677, X51970; B: D23678, AB073838; C: D50489, Y18855; D: AB090270, AF151735; E: AB032431, X75657; F: AB036905, AB036907; G: AB064313, AB056513 and H: AY090454, AY090457). </plain></SENT>
<SENT sid="78" pm="."><plain>The alignment was converted in MEGA format using MEGA 6.06 software.15 The phylogenetic tree was constructed by the Maximum composite likelihood algorithm with a bootstrap test of 1000 replicates.16 Significance of polymerase gene fragment sequence for genotyping was evaluated by phylogenetic analysis of reference sequences of all genotypes (A-H) obtained from NCBI genotyping tool reference set and GenBank database. </plain></SENT>
<SENT sid="79" pm="."><plain>This reference set includes total 66 sequences. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="80" pm="."><plain>Genetic distance </plain></SENT>
</text></title><p><text><SENT sid="81" pm="."><plain>An analysis of the number of base substitutions per site between the nucleotide sequences (genetic distance (d)) was conducted using the maximum composite likelihood method in MEGA 6.06 for reference sequences from each genotype used for phylogenetic analysis. </plain></SENT>
<SENT sid="82" pm="."><plain>Analyses were conducted using the Maximum Composite Likelihood model. </plain></SENT>
<SENT sid="83" pm="."><plain>The differences in the composition bias among sequences were considered in evolutionary comparisons. </plain></SENT>
<SENT sid="84" pm="."><plain>The analysis involved 16 nucleotide sequences. </plain></SENT>
<SENT sid="85" pm="."><plain>Similarity matrix was derived from the distance analysis. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="86" pm="."><plain>Evolutionary substitution rates </plain></SENT>
</text></title><p><text><SENT sid="87" pm="."><plain>Different genotypes are evolved due to substitution mutations at different sites within the viral genome.17 To determine the sites that are highly prone to substitutions, we performed the substitution rate analysis using MEGA 6.06. </plain></SENT>
<SENT sid="88" pm="."><plain>Substitution pattern and rates were estimated under the Tamura-Nei (1993) model (+G).18 A discrete Gamma distribution was used to model evolutionary rate differences among sites (5 categories, [+G]).19 </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="89" pm="."><plain>Determination of drug resistance mutations </plain></SENT>
</text></title><p><text><SENT sid="90" pm="."><plain>Drug resistance interpretation based on mutation in HBV polymerase gene was inferred by submitting the sequence data to Stanford University database (<ext-link ext-link-type="uri" xlink:href="http://hivdb.stanford.edu/HBV/HBVseq">http://hivdb.stanford.edu/HBV/HBVseq</ext-link>) and Geno2pheno (hbv) resistance prediction tool (<ext-link ext-link-type="uri" xlink:href="http://hbv.geno2pheno.org">http://hbv.geno2pheno.org</ext-link>) (Max Planck Institute) </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="91" pm="."><plain>Statistical analysis </plain></SENT>
</text></title><p><text><SENT sid="92" pm="."><plain>Clinical characteristics, mean and frequency of genotyping data were analysed using a SPSS statistics (2014) and Microsoft Excel (2013). </plain></SENT>
<SENT sid="93" pm="."><plain>Descriptive statistics are presented as proportions, means ± standard deviation, and medians with interquartile range. </plain></SENT>
<SENT sid="94" pm="."><plain>Comparative analyses were performed using the Student's t-test and Chi square test. </plain></SENT>
<SENT sid="95" pm="."><plain>A P value of less than 0.05 was considered significant. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results"><title><text><SENT sid="96" pm="."><plain>Results </plain></SENT>
</text></title><p><text><SENT sid="97" pm="."><plain>Clinical characteristics of study patients infected with HBV are provided in Table 1. </plain></SENT>
<SENT sid="98" pm="."><plain>All the patients were from state of Maharashtra geographically located in Western India. </plain></SENT>
<SENT sid="99" pm="."><plain>Mean HBV viral load of study samples was 4.46 + 1.77 HBV DNA IU/mL. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><text><SENT sid="100" pm="."><plain>Clinical characteristics of study patients infected with Hepatitis B Virus </plain></SENT>
</text></p></caption><table frame="box" rules="all"><thead><tr><td rowspan="1" colspan="1"><text><SENT sid="101" pm="."><plain>Variables </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="102" pm="."><plain>Population (n= 98) </plain></SENT>
</text></td></tr></thead><tbody><tr><td rowspan="1" colspan="1"><text><SENT sid="103" pm="."><plain>Age, years </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="104" pm="."><plain>43.8 ± 11.6 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="105" pm="."><plain>Male/Female, n (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="106" pm="."><plain>70/28 (71.43%/28.57%) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="107" pm="."><plain>HBsAg, positive </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="108" pm="."><plain>98 (100%) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="109" pm="."><plain>HBeAg, positive </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="110" pm="."><plain>98 (100%) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="111" pm="."><plain>Serum ALT (U/L) ± SD </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="112" pm="."><plain>86.10 ± 32.54 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="113" pm="."><plain>HBV DNA positive, n (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="114" pm="."><plain>98 (100%) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="115" pm="."><plain>HBV viral load, log10 IU/mL (range, HBV DNA IU/mL) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="116" pm="."><plain>4.46 ± 1.77 (7-110000000 HBV DNA IU/mL) </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag></sec></SecTag><sec><title><text><SENT sid="117" pm="."><plain>PCR amplification of HBV pol gene </plain></SENT>
</text></title><p><text><SENT sid="118" pm="."><plain>Hepatitis B Virus DNA isolated from patients generated 409 bp PCR amplification product for pol gene using nested PCR approach (Figure 1). </plain></SENT>
<SENT sid="119" pm="."><plain>In total, all 98 (100%) samples were positive for polymerase gene fragments. </plain></SENT>
<SENT sid="120" pm="."><plain>Each of these nested PCR reaction products were then sequenced. </plain></SENT>
<SENT sid="121" pm="."><plain>The nucleotide sequence data was submitted to GenBank, these sequences are available at NCBI nucleotide sequence database with accession number KM076939-KM077016. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F1" fig-type="illustration" position="float"><label>Figure 1</label><caption><p><text><SENT sid="122" pm="."><plain>Agarose gel electrophoresis (2% w/v) of the nested PCR products and DNA marker. </plain></SENT>
<SENT sid="123" pm="."><plain>200 bp DNA ladder (Lane M), second round of amplification products (Lane 1–8). </plain></SENT>
</text></p></caption><graphic xlink:href="AFHS1703-0762Fig1"/></fig></SecTag></sec><SecTag type="METHODS"><sec><title><text><SENT sid="124" pm="."><plain>Determination of HBV genotypes and phylogenetic analysis </plain></SENT>
</text></title><p><text><SENT sid="125" pm="."><plain>Three major genotypes A, C and D were found within the study population as predicted by NCBI genotyping tool for HBV. </plain></SENT>
<SENT sid="126" pm="."><plain>HBV Genotype D (n=76; 77.55%) was found to be predominant circulating genotype (p &lt; 0.05), followed by C (n=18; 18.37%) and A (n=4; 4.08%) among 98 sequences. </plain></SENT>
<SENT sid="127" pm="."><plain>Geno2pheno and HBVSeq Programs also determined genotypes and subgenotypes of the sequences. </plain></SENT>
<SENT sid="128" pm="."><plain>Six sub-genotypes were detected A1, C1, C2, D2, D3 and D4, of which HBV sub-genotypes D2 (n=65; 66.33%). </plain></SENT>
<SENT sid="129" pm="."><plain>Clinical and demographic characteristics of the study population with respect to sub-genotypes distribution are provided in Table 2. </plain></SENT>
<SENT sid="130" pm="."><plain>Higher levels of Serum ALT (110.33 +42.54 U/L) were observed in sub-genotypes A1. </plain></SENT>
<SENT sid="131" pm="."><plain>Genotype prediction from NCBI genotyping tool, Geno2Pheno and HBVSeq produced 100% similar results. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T2" position="float"><label>Table 2</label><caption><p><text><SENT sid="132" pm="."><plain>Clinical and demographic characteristic of the study population with respect to sub-genotypes distribution. </plain></SENT>
</text></p></caption><table frame="box" rules="all"><thead valign="top"><tr><td rowspan="1" colspan="1"><text><SENT sid="133" pm="."><plain>Genotype </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="134" pm="."><plain>A (n=4) </plain></SENT>
</text></td><td colspan="2" align="left" rowspan="1"><text><SENT sid="135" pm="."><plain>C (n=18) </plain></SENT>
</text></td><td colspan="3" align="left" rowspan="1"><text><SENT sid="136" pm="."><plain>D (n=76) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="137" pm="."><plain>Subgenotype </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="138" pm="."><plain>A1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="139" pm="."><plain>C1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="140" pm="."><plain>C2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="141" pm="."><plain>D2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="142" pm="."><plain>D3 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>D4 </plain></SENT>
</text></td></tr></thead><tbody valign="middle"><tr><td rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain>Number of samples (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="145" pm="."><plain>4 (4.08) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain>7 (7.14) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>11 (11.22) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain>65 (66.33) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="149" pm="."><plain>1 (1.02) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>10(10.20) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>Male/Female (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain>4/0 (100/0) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>6/1 (85.71/14.29) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="154" pm="."><plain>6/5 (54.55/45.45) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="155" pm="."><plain>45/20 (69.23/30.77) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain>1/0 (100/0) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain>8/2 (80/20) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="158" pm="."><plain>Age, years (range) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain>38.0 ± 11.69 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain>41.57 ± 5.32 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain>43.36 ± 8.49 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain>45.12 ± 12.65 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>49.0 ± 0.00 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain>39.3 ± 10.88 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="165" pm="."><plain>Serum ALT (U/L) (range) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="166" pm="."><plain>110.33 ± 42.54 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="167" pm="."><plain>96.52 ± 40.20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="168" pm="."><plain>86.00 ± 30.51 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="169" pm="."><plain>82.57 ± 31.96 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="170" pm="."><plain>72.00 ± 0.00 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="171" pm="."><plain>93.57 ± 30.31 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="172" pm="."><plain>HBV viral load, log10 copies/mL (range) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="173" pm="."><plain>4.17 ± 1.44 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="174" pm="."><plain>4.70 ± 2.03 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="175" pm="."><plain>3.22 ± 1.27 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="176" pm="."><plain>4.51 ± 1.77 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="177" pm="."><plain>3.25 ± 0.00 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="178" pm="."><plain>5.55 ± 1.71 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="179" pm="."><plain>Common Mutations (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="180" pm="."><plain>I253V (100) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="181" pm="."><plain>N226H (85), Q267L (85) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="182" pm="."><plain>S223A (100), I224V(100), V253I (91), Q267H(45), I282V (45) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="183" pm="."><plain>N248H (49), D263E (23) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="184" pm="."><plain>N248H (100), C256S (100) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="185" pm="."><plain>N248H (40), E271D (60) </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag></sec></SecTag><SecTag type="METHODS"><sec><title><text><SENT sid="186" pm="."><plain>Phylogenetic analysis </plain></SENT>
</text></title><p><text><SENT sid="187" pm="."><plain>Phylogenetic analysis based on alignment of nucleotide sequences of HBV polymerase gene from 78 study samples and 16 representative reference sequences (NCBI GenBank database) was used to confirm the presence of genotype A, C and D. As evident from phylogenetic tree presented in Figure 2, Genotype A, C and D samples clustered with closest reference sequences of the same genotype. </plain></SENT>
<SENT sid="189" pm="."><plain>The evolutionary history was inferred using the UPGMA method. </plain></SENT>
<SENT sid="190" pm="."><plain>Phylogenetic analysis of 66 reference sequences obtained from NCBI GenBank database showed distinct clustering of each genotype proving the significance of use of polymerase gene fragment sequence in HBV genotyping. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F2" fig-type="illustration" position="float"><label>Figure 2</label><caption><p><text><SENT sid="191" pm="."><plain>Phylogenetic analysis of Hepatitis B Virus (HBV) based on partial sequence of polymerase gene from 78 study samples and 16 reference sequences representing each genotype. </plain></SENT>
<SENT sid="192" pm="."><plain>Numbers at respective nodes represent percentage bootstrap values (1000 replicates). </plain></SENT>
<SENT sid="193" pm="."><plain>The Maximum-Likelihood tree was constructed with a substitution model of Tamura-Nei plus gamma distribution using MEGA software 6.06. </plain></SENT>
<SENT sid="194" pm="."><plain>As the branch lengths and bootstrap values between various genotype D sequences were low or zero, the tree has been represented in topology view to make ancestor-descendant relationship clear, hence the scale bar was removed. </plain></SENT>
</text></p></caption><graphic xlink:href="AFHS1703-0762Fig2"/></fig></SecTag><p><text><SENT sid="195" pm="."><plain>Figure 3 shows distinct branches for each genotype supported by significant bootstrap values. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F3" fig-type="illustration" position="float"><label>Figure 3</label><caption><p><text><SENT sid="196" pm="."><plain>Phylogenetic analysis of 66 reference sequences for polymerase gene obtained from NCBI GenBank database using Maximum-Likelihood Method. </plain></SENT>
<SENT sid="197" pm="."><plain>Branch reliability is indicated by the percentage of bootstrap values at each node (1,000 replications). </plain></SENT>
<SENT sid="198" pm="."><plain>The scale bar indicates the number of base substitutions per site. </plain></SENT>
<SENT sid="199" pm="."><plain>Lower rectangle represent each genotype distributed amongst branches within the tree. </plain></SENT>
</text></p></caption><graphic xlink:href="AFHS1703-0762Fig3"/></fig></SecTag></sec></SecTag><sec><title><text><SENT sid="200" pm="."><plain>Genetic distances </plain></SENT>
</text></title><p><text><SENT sid="201" pm="."><plain>When all eight genotypes were compared to each other (Table 3), HBV genotypes showed genetic divergence ranging from 6.7 (genotype A B) to 18.4 (genotype C → H) based on sequence polymorphism in polymerase gene. </plain></SENT>
<SENT sid="202" pm="."><plain>The nucleotide sequence similarity ranged from 81.6 (genotype C → H) to 93.3 (genotype A → B). </plain></SENT>
<SENT sid="203" pm="."><plain>This analysis included two sequences for each genotype hence inter-genotypic and intra-genotypic divergence was also determined. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T3" position="float"><label>Table 3</label><caption><p><text><SENT sid="204" pm="."><plain>Nucleotide sequence similarity and divergence of polymerase gene among HBV genotypes reference sequence obtained from NCBIGenBank database </plain></SENT>
</text></p></caption><table frame="box" rules="all"><thead valign="middle"><tr><td rowspan="2" align="center" colspan="1"><text><SENT sid="205" pm="."><plain>Genotype </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="206" pm="."><plain>Genotype </plain></SENT>
</text></td><td colspan="2" align="center" rowspan="1"><text><SENT sid="207" pm="."><plain>D </plain></SENT>
</text></td><td colspan="2" align="center" rowspan="1"><text><SENT sid="208" pm="."><plain>G </plain></SENT>
</text></td><td colspan="2" align="center" rowspan="1"><text><SENT sid="209" pm="."><plain>A </plain></SENT>
</text></td><td colspan="2" align="center" rowspan="1"><text><SENT sid="210" pm="."><plain>B </plain></SENT>
</text></td><td colspan="2" align="center" rowspan="1"><text><SENT sid="211" pm="."><plain>C </plain></SENT>
</text></td><td colspan="2" align="center" rowspan="1"><text><SENT sid="212" pm="."><plain>E </plain></SENT>
</text></td><td colspan="2" align="center" rowspan="1"><text><SENT sid="213" pm="."><plain>F </plain></SENT>
</text></td><td colspan="2" align="center" rowspan="1"><text><SENT sid="214" pm="."><plain>H </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="215" pm="."><plain>Accession number </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="216" pm="."><plain>AB090270 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="217" pm="."><plain>AF151735 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="218" pm="."><plain>AB064313 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="219" pm="."><plain>AB056513 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="220" pm="."><plain>AF418677 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="221" pm="."><plain>X51970 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="222" pm="."><plain>D23678 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="223" pm="."><plain>AB073838 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="224" pm="."><plain>D50489 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="225" pm="."><plain>Y18855 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="226" pm="."><plain>AB032431 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="227" pm="."><plain>X75657 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="228" pm="."><plain>AB036907 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="229" pm="."><plain>AB036905 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="230" pm="."><plain>AY090454 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="231" pm="."><plain>AY090457 </plain></SENT>
</text></td></tr></thead><tbody valign="middle"><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="232" pm="."><plain>D </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="233" pm="."><plain>AB090270 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="234" pm="."><plain>97.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="235" pm="."><plain>88.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="236" pm="."><plain>89.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="237" pm="."><plain>90.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="238" pm="."><plain>91.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="239" pm="."><plain>88.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="240" pm="."><plain>88.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="241" pm="."><plain>86.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="242" pm="."><plain>87.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="243" pm="."><plain>90.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="244" pm="."><plain>91.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="245" pm="."><plain>84.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="246" pm="."><plain>84.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="247" pm="."><plain>83.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="248" pm="."><plain>83.9 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="249" pm="."><plain>AF151735 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="250" pm="."><plain>2.3 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="251" pm="."><plain>87.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="252" pm="."><plain>88.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="253" pm="."><plain>89.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="254" pm="."><plain>89.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="255" pm="."><plain>86.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="256" pm="."><plain>86.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="257" pm="."><plain>84.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="258" pm="."><plain>85.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="259" pm="."><plain>89.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="260" pm="."><plain>90.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="261" pm="."><plain>83.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="262" pm="."><plain>83.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="263" pm="."><plain>82.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="264" pm="."><plain>83.2 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="265" pm="."><plain>G </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="266" pm="."><plain>AB064313 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="267" pm="."><plain>11.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="268" pm="."><plain>12.1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="269" pm="."><plain>99.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="270" pm="."><plain>89.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="271" pm="."><plain>89.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="272" pm="."><plain>89.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="273" pm="."><plain>88.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>86.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>86.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>88.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>88.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>81.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>81.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>82.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>82.5 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>AB056513 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="283" pm="."><plain>10.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>11.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>0.3 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>89.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>89.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>89.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>88.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="290" pm="."><plain>86.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>87.0 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>88.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>88.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="294" pm="."><plain>82.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="295" pm="."><plain>82.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="296" pm="."><plain>82.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="297" pm="."><plain>82.9 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="298" pm="."><plain>A </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="299" pm="."><plain>AF418677 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="300" pm="."><plain>9.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="301" pm="."><plain>10.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="302" pm="."><plain>10.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="303" pm="."><plain>10.4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="304" pm="."><plain>96.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="305" pm="."><plain>92.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="306" pm="."><plain>92.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>90.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>90.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>91.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>93.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>85.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>85.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>85.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>85.6 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>X51970 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>8.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>10.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>10.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>10.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>3.4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>93.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>93.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>90.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>89.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="325" pm="."><plain>91.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="326" pm="."><plain>92.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>85.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>85.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="329" pm="."><plain>85.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="330" pm="."><plain>86.3 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="331" pm="."><plain>B </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>D23678 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>11.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>13.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>10.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>10.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="337" pm="."><plain>7.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>6.7 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="339" pm="."><plain>98.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="340" pm="."><plain>91.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="341" pm="."><plain>90.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="342" pm="."><plain>90.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="343" pm="."><plain>91.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="344" pm="."><plain>83.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="345" pm="."><plain>83.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="346" pm="."><plain>84.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="347" pm="."><plain>84.7 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="348" pm="."><plain>AB073838 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="349" pm="."><plain>11.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="350" pm="."><plain>13.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>11.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="352" pm="."><plain>11.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="353" pm="."><plain>7.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="354" pm="."><plain>6.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="355" pm="."><plain>1.7 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="356" pm="."><plain>91.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="357" pm="."><plain>90.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="358" pm="."><plain>90.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>91.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>83.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>83.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>84.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>85.1 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="364" pm="."><plain>C </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>D50489 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>13.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>15.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>13.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="369" pm="."><plain>13.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="370" pm="."><plain>9.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>9.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="372" pm="."><plain>8.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>8.9 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="374" pm="."><plain>97.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>88.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>89.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>82.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="378" pm="."><plain>82.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>82.0 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>82.3 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>Y18855 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="382" pm="."><plain>12.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="383" pm="."><plain>14.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="384" pm="."><plain>13.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="385" pm="."><plain>13.0 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="386" pm="."><plain>9.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="387" pm="."><plain>10.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>9.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>9.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="390" pm="."><plain>2.5 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="391" pm="."><plain>87.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="392" pm="."><plain>88.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="393" pm="."><plain>83.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="394" pm="."><plain>83.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="395" pm="."><plain>81.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="396" pm="."><plain>82.0 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="397" pm="."><plain>E </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="398" pm="."><plain>AB032431 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>9.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="400" pm="."><plain>10.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>11.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="402" pm="."><plain>11.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="403" pm="."><plain>8.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="404" pm="."><plain>8.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="405" pm="."><plain>9.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="406" pm="."><plain>9.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>11.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>12.4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>97.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="410" pm="."><plain>84.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>84.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="412" pm="."><plain>82.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>82.9 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="414" pm="."><plain>X75657 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="415" pm="."><plain>8.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>9.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>11.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="418" pm="."><plain>11.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>6.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="420" pm="."><plain>7.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>8.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="422" pm="."><plain>8.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="423" pm="."><plain>10.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="424" pm="."><plain>11.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="425" pm="."><plain>2.6 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="426" pm="."><plain>84.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="427" pm="."><plain>84.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>83.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>84.3 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="430" pm="."><plain>F </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="431" pm="."><plain>AB036907 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="432" pm="."><plain>15.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="433" pm="."><plain>16.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="434" pm="."><plain>18.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="435" pm="."><plain>17.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="436" pm="."><plain>14.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="437" pm="."><plain>14.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="438" pm="."><plain>16.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="439" pm="."><plain>16.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="440" pm="."><plain>17.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>16.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="442" pm="."><plain>15.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="443" pm="."><plain>15.2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="444" pm="."><plain>100.0 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="445" pm="."><plain>89.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>90.2 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>AB036905 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="448" pm="."><plain>15.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>16.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="450" pm="."><plain>18.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="451" pm="."><plain>17.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="452" pm="."><plain>14.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="453" pm="."><plain>14.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="454" pm="."><plain>16.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="455" pm="."><plain>16.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>17.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>16.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>15.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>15.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="460" pm="."><plain>0.0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>89.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="462" pm="."><plain>90.2 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="463" pm="."><plain>H </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="464" pm="."><plain>AY090454 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="465" pm="."><plain>16.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="466" pm="."><plain>17.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="467" pm="."><plain>17.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="468" pm="."><plain>17.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="469" pm="."><plain>14.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="470" pm="."><plain>14.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>15.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="472" pm="."><plain>15.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="473" pm="."><plain>18.0 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>18.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>17.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="476" pm="."><plain>16.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="477" pm="."><plain>10.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="478" pm="."><plain>10.4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="479" pm="."><plain>99.4 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="480" pm="."><plain>AY090457 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="481" pm="."><plain>16.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="482" pm="."><plain>16.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="483" pm="."><plain>17.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>17.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>14.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>13.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>15.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>14.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>17.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="490" pm="."><plain>18.0 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="491" pm="."><plain>17.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>15.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>9.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>9.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="495" pm="."><plain>0.6 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></SecTag></sec><sec><title><text><SENT sid="496" pm="."><plain>Evolutionary substitution rates </plain></SENT>
</text></title><p><text><SENT sid="497" pm="."><plain>All sequences were distributed under five different Gamma categories based on the sequence divergence and types of substitutions. </plain></SENT>
<SENT sid="498" pm="."><plain>Mean evolutionary rates in these categories were 0.00, 0.05, 0.25, 0.90, 3.80 substitutions per site. </plain></SENT>
<SENT sid="499" pm="."><plain>The nucleotide frequencies were A = 25.03%, T = 34.81%, C = 19.43%, and G = 20.73%. </plain></SENT>
<SENT sid="500" pm="."><plain>For estimating ML values, a tree topology was automatically computed. </plain></SENT>
<SENT sid="501" pm="."><plain>The maximum Log likelihood for this computation was −2972.224. </plain></SENT>
<SENT sid="502" pm="."><plain>The estimated value of the shape parameter for the discrete Gamma Distribution is 0.2961. </plain></SENT>
<SENT sid="503" pm="."><plain>These nucleotide substitution rates are scaled such that the average evolutionary rate across all sites is 1. </plain></SENT>
<SENT sid="504" pm="."><plain>This means that sites showing a rate &lt; 1 are evolving slower than average. </plain></SENT>
<SENT sid="505" pm="."><plain>Nucleotide positions with substitution rate less than 1 (Mean (relative) evolutionary rate &lt;1) were 237/336 whereas the number of sites with &gt;1 substitution rate (Mean (relative) evolutionary rate &gt;1) were 99/336. </plain></SENT>
<SENT sid="506" pm="."><plain>Hence the sequence studied has 29.46% nucleotide positions which are evolving faster than average. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="507" pm="."><plain>HBV drug resistance interpretation </plain></SENT>
</text></title><p><text><SENT sid="508" pm="."><plain>Genotypic resistance mutations against lamivudine (L180M, M204V/I), adefovir (A181T, N236S), and entecavir (I169M, A184T/V, S202I/G, M250V/I/L) were not detected in any patient. </plain></SENT>
<SENT sid="509" pm="."><plain>Genotypic variants were detected as other mutations that may not be responsible for drug resistance. </plain></SENT>
<SENT sid="510" pm="."><plain>The mutations with greater than 5% incidence rate in study population have been provided along with their frequency in Table 4. </plain></SENT>
<SENT sid="511" pm="."><plain>Mutation at 248th amino acid (N248H) of DNA polymerase gene was the most common genotypic variant found in 32.65% (32/98) of population. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T4" position="float"><label>Table 4</label><caption><p><text><SENT sid="512" pm="."><plain>The mutations in HBV polymerase gene of study samples with greater than 5% incidence rate </plain></SENT>
</text></p></caption><table frame="box" rules="all"><thead><tr><td rowspan="1" colspan="1"><text><SENT sid="513" pm="."><plain>Mutation Site </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="514" pm="."><plain>Number of patients with mutation (% Rate) </plain></SENT>
</text></td></tr></thead><tbody><tr><td rowspan="1" colspan="1"><text><SENT sid="515" pm="."><plain>N248H </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="516" pm="."><plain>32 (32.65) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="517" pm="."><plain>I253V, D263E </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="518" pm="."><plain>16 (16.33) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="519" pm="."><plain>E271D, V253I </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="520" pm="."><plain>10 (10.20) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="521" pm="."><plain>Q267L, I266R </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="522" pm="."><plain>7 (7.14) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>I282V, N226H, S213T, I266T, S219A </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="524" pm="."><plain>6 (6.12) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="525" pm="."><plain>Q267H, C256G, N238H, D263S </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="526" pm="."><plain>5 (5.10) </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag></sec><SecTag type="DISCUSS"><sec sec-type="discussion"><title><text><SENT sid="527" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="528" pm="."><plain>Traditional HBV genotyping methods using restriction fragment length polymorphism (RFLP) have been developed and used extensively for HBV genotypes A to H.20 Genotyping methods that use multiplex PCR with type-specific primers have also been reported.13 However, most of these newer methods are based on analyzing the S gene. </plain></SENT>
<SENT sid="529" pm="."><plain>Here we employed genotyping method based on a segment of the HBV DNA polymerase gene. </plain></SENT>
</text></p><p><text><SENT sid="530" pm="."><plain>This study demonstrated that using HBV DNA polymerase gene sequence all the different genotypes show distinct clades in phylogenetic analysis and hence the gene fragment used for analysis is a suitable target for HBV genotyping. </plain></SENT>
<SENT sid="531" pm="."><plain>As evident from phylogenetic tree, based on the clusters formed by genotypes A–H, the sequences obtained from HBV DNA polymerase gene from patients can be classified under these genotypes. </plain></SENT>
</text></p><p><text><SENT sid="532" pm="."><plain>In this study, the predominant genotype of Hepatitis B was found to be genotype D, and there were no patients with drug resistant HBV. </plain></SENT>
<SENT sid="533" pm="."><plain>As per previous reports, genotype C is less reported in India, however we found 18 out of 98 cases to be genotype C which indicates substantial increase in infections with genotype C in Indian population.21 The variation in relative frequency of HBV genotypes reported in studies from India by various authors have confirmed that the genotype D has been predominant among others.22 Therefore, the fragment of HBV DNA polymerase gene as a target for genotyping hepatitis B in India has been proved to be significant. </plain></SENT>
<SENT sid="534" pm="."><plain>This genotyping method can also be used to predict antiviral therapeutic response among HBV genotypes and the development of drug resistance due to mutations. </plain></SENT>
<SENT sid="535" pm="."><plain>The fragment covers clinically important YMDD domain of polymerase gene, mutations which are responsible for failure of anti-viral therapy. </plain></SENT>
<SENT sid="536" pm="."><plain>Hence using the same sequence data, interpretation of drug resistance in HBV is possible. </plain></SENT>
<SENT sid="537" pm="."><plain>It is a valuable tool for guiding the treatment of lamivudine-resistant HBV in different clinical settings.23 Nucleotide sequence analysis of HBV DNA polymerase gene in all patient samples using different genotyping algorithms detected genotypes A, C and D whereas genotypes B, E, F, G and H were not detected. </plain></SENT>
</text></p><p><text><SENT sid="538" pm="."><plain>Of the eight genotypes of HBV, infection with HBV genotype D is the most common in India. </plain></SENT>
<SENT sid="539" pm="."><plain>Infection with genotype D is associated with more severe liver disease than genotype A.24 The major route of HBV transmission in acute hepatitis seem to be sexual intercourse, frequent international travel and contact with people from different ethnic backgrounds, which may contribute to change in the predominance pattern of genotypes in a geographical location.25 This study demonstrated that the patients suffering from HBV infection were infected with different genotypes as D, C and A, suggesting no significant change in predominance of HBV genotype in hepatitis B infected cases. </plain></SENT>
</text></p><p><text><SENT sid="540" pm="."><plain>Drug resistant viral strains are evolved due to increased use of anti-viral drugs to treat chronic hepatitis B, such as lamivudine, adefovir, telbivudine, and entecavir.26 In absence of anti-viral drugs and drug pressure, most of the drug resistant mutants do not survive and may not remain as fit as the wild type virus in an acutely infected liver.27,28 In contrast, natural resistance mutations in treatment-naive chronic hepatitis B patients may exist. </plain></SENT>
<SENT sid="541" pm="."><plain>Mutation substitution rates in polymerase gene as per our study reveal the number of nucleotide position which are more prone to mutations indicating that such changes may drive incidence of drug resistance as well as different genotypes. </plain></SENT>
<SENT sid="542" pm="."><plain>Our study was limited to genotype D, C and A due to non-availability of samples from other genotypes, larger studies that include samples from patients with all HBV genotypes are required to represent data for all genotypes. </plain></SENT>
</text></p></sec></SecTag><SecTag type="CONCL"><sec sec-type="conclusions"><title><text><SENT sid="543" pm="."><plain>Conclusion </plain></SENT>
</text></title><p><text><SENT sid="544" pm="."><plain>The study reports Hepatitis B Virus genotyping using DNA polymerase gene fragment sequencing as an effective tool to determine the HBV genotypes as well as drug resistance mutations in HBV infected patients. </plain></SENT>
<SENT sid="545" pm="."><plain>This study reports high prevalence of genotype D which is in concordance with previous studies. </plain></SENT>
<SENT sid="546" pm="."><plain>It provides a useful alternative to complete sequencing of the HBV genome and allows the study genetic variation between various genotypes and drug resistance mutations responsible for anti-viral drug failure. </plain></SENT>
<SENT sid="547" pm="."><plain>Genotyping data of HBV via sequence of DNA polymerase fragment from various geographical population can be generated to validate this method in different populations. </plain></SENT>
<SENT sid="548" pm="."><plain>One of the studies reported from China demonstrated the significance of HBV DNA polymerase gene sequencing based genotyping and drug resistance interpretation.10 Future studies in patients at different stages of infection and therapeutic treatment would help us in understanding the relevance of genotype, resistance mutations and response of the patient to a particular therapy. </plain></SENT>
<SENT sid="549" pm="."><plain>These studies can be carried out to investigate the clinical, virological and therapeutical response characteristics of HBV genotypes, with clinical data such that the status of HBV infection can be characterized (carrier, immunotolerant, acute and chronic hepatitis, cirrhosis) using a large population size. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><title>Acknowledgement</title><p><text4fund><text><SENT sid="550" pm="."><plain>Authors are thankful to Mr. </plain></SENT>
<SENT sid="551" pm="."><plain>Hrishikesh Joshi from Gene-Support (India) for writing and proof reading assistance during preparation of the manuscript. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="ABBR"><glossary><title>Abbreviations</title><def-list id="DL1"><def-item><term>CHB</term><def><p>Chronic Hepatitis</p></def></def-item><def-item><term>S</term><def><p>Sustained viral respon</p></def></def-item></def-list></glossary></SecTag><SecTag type="COMP_INT"><sec><title>Conflict of interest</title><p>Authors declare no conflict of interest.</p></sec></SecTag><SecTag type="REF"><ref-list><ref id="R1"><text><SENT sid="552" pm="."><plain>1KumarADwivediMMisraSPNarangSTiwariBKPandeyRClinical profile, genotype and management updates of hepatitis B virusIndian J Virol20112211023637496 </plain></SENT>
</text></ref><ref id="R2"><text><SENT sid="553" pm="."><plain>2AndernachIEHubschenJMMullerCPHepatitis B virus: the genotype E puzzleRev Med Virol20091923124019475565 </plain></SENT>
</text></ref><ref id="R3"><text><SENT sid="554" pm="."><plain>3YousifMKramvisAGenotype D of hepatitis B virus and its subgenotypes: An updateHepatol Res20134335536422978460 </plain></SENT>
</text></ref><ref id="R4"><text><SENT sid="555" pm="."><plain>4QinYTangXGarciaTHussainMZhangJLokAHepatitis B virus genotype C isolates with wild-type core promoter sequence replicate less efficiently than genotype B isolates but possess higher virion secretion capacityJ Virol201185101671017721775451 </plain></SENT>
</text></ref><ref id="R5"><text><SENT sid="556" pm="."><plain>5TsubotaAAraseYRenFTanakaHIkedaKKumadaHGenotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adwJ Med Virol20016525726511536231 </plain></SENT>
</text></ref><ref id="R6"><text><SENT sid="557" pm="."><plain>6CaoGWClinical relevance and public health significance of hepatitis B virus genomic variationsWorld J Gastroenterol2009155761576919998495 </plain></SENT>
</text></ref><ref id="R7"><text><SENT sid="558" pm="."><plain>7KobayashiMAraseYIkedaKTsubotaASuzukiYSaitohSClinical characteristics of patients infected with hepatitis B virus genotypes A, B, and CJ Gastroenterol200237353911824798 </plain></SENT>
</text></ref><ref id="R8"><text><SENT sid="559" pm="."><plain>8MayeratCManteganiAFreiPCDoes hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?J Viral Hepat19996299304PubMed10607244 </plain></SENT>
</text></ref><ref id="R9"><text><SENT sid="560" pm="."><plain>9ThakurVSarinSKRehmanSGuptanRCKazimSNKumarSRole of HBV genotype in predicting response to lamivudine therapy in patients with chronic hepatitis BIndian J Gastroenterol200524121515778519 </plain></SENT>
</text></ref><ref id="R10"><text><SENT sid="561" pm="."><plain>10MaYDingYJuanFDouXGGenotyping the hepatitis B virus with a fragment of the HBV DNA polymerase gene in Shenyang, ChinaVirol J2011831521693069 </plain></SENT>
</text></ref><ref id="R11"><text><SENT sid="562" pm="."><plain>11YehSHTsaiCYKaoJHLiuCJKuoTJLinMWQuantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysisJ Hepatol20044165966615464248 </plain></SENT>
</text></ref><ref id="R12"><text><SENT sid="563" pm="."><plain>12LarkinMABlackshieldsGBrownNPChennaRMcGettiganPAMcWilliamHClustal W and Clustal X version 2.0Bioinformatics2007232947294817846036 </plain></SENT>
</text></ref><ref id="R13"><text><SENT sid="564" pm="."><plain>13ChenJYinJTanXZhangHZhangHChenBImproved multiplex-PCR to identify hepatitis B virus genotypes A–F and subgenotypes B1, B2, C1 and C2J Clin Virol20073823824317224304 </plain></SENT>
</text></ref><ref id="R14"><text><SENT sid="565" pm="."><plain>14LusidaMINugrahaputraVESoetjipto HandajaniRNagano-FujiiMSasayamaMNovel subgenotypes of hepatitis B virus genotypes C and D in Papua, IndonesiaJ Clin Microbiol2008462160216618463220 </plain></SENT>
</text></ref><ref id="R15"><text><SENT sid="566" pm="."><plain>15TamuraKStecherGPetersonDFilipskiAKumarSMEGA6: Molecular Evolutionary Genetics Analysis version 6.0Mol Biol Evol2013302725272924132122 </plain></SENT>
</text></ref><ref id="R16"><text><SENT sid="567" pm="."><plain>16FelsensteinJEstimating effective population size from samples of sequences: a bootstrap Monte Carlo integration methodGenet Res1992602092201286805 </plain></SENT>
</text></ref><ref id="R17"><text><SENT sid="568" pm="."><plain>17FaresMAHolmesECA revised evolutionary history of hepatitis B virus (HBV)J Mol Evol20025480781412029362 </plain></SENT>
</text></ref><ref id="R18"><text><SENT sid="569" pm="."><plain>18TamuraKNeiMEstimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzeesMol Biol Evol1993105125268336541 </plain></SENT>
</text></ref><ref id="R19"><text><SENT sid="570" pm="."><plain>19TamuraKKumarSEvolutionary distance estimation under heterogeneous substitution pattern among lineagesMol Biol Evol2002191727173612270899 </plain></SENT>
</text></ref><ref id="R20"><text><SENT sid="571" pm="."><plain>20ZengGBWenSJWangZHYanLSunJHouJLA novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene ampliconsWorld J Gastroenterol2004103132313615457558 </plain></SENT>
</text></ref><ref id="R21"><text><SENT sid="572" pm="."><plain>21KumarAKumarSIPandeyRNaikSAggarwalRHepatitis B virus genotype A is more often associated with severe liver disease in Northern India than is genotype DIndian J Gastroenterol200524192215778521 </plain></SENT>
</text></ref><ref id="R22"><text><SENT sid="573" pm="."><plain>22GandheSSChadhaMSArankalleVAHepatitis B virus genotypes and serotypes in Western India: lack of clinical significanceJ Med Virol20036932433012526041 </plain></SENT>
</text></ref><ref id="R23"><text><SENT sid="574" pm="."><plain>23PanXPLiLJDuWBLiMWCaoHCShengJFDifferences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and CJ Viral Hepat20071476777417927612 </plain></SENT>
</text></ref><ref id="R24"><text><SENT sid="575" pm="."><plain>24Amini-Bavil-OlyaeeSHosseiniSYSabahiFAlavianSMHepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudineInt J Infect Dis200812838717698384 </plain></SENT>
</text></ref><ref id="R25"><text><SENT sid="576" pm="."><plain>25TeHSJensenDMEpidemiology of hepatitis B and C viruses: a global overviewClin Liver Dis20101412120123436 </plain></SENT>
</text></ref><ref id="R26"><text><SENT sid="577" pm="."><plain>26YimHJHussainMLiuYWongSNFungSKLokASEvolution of multi-drug resistant hepatitis B virus during sequential therapyHepatology20064470371216941700 </plain></SENT>
</text></ref><ref id="R27"><text><SENT sid="578" pm="."><plain>27LiuYWangCMChengJLiangZLZhongYWRenXQHepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibilityChin Med J (Engl)20091221585158619719953 </plain></SENT>
</text></ref><ref id="R28"><text><SENT sid="579" pm="."><plain>28ZoulimFLocarniniSHepatitis B virus resistance to nucleos(t)ide analoguesGastroenterology200913715931608e1e219737565 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
